These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7906583

  • 1. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer.
    Silvestrini R, Zaffaroni N, Orlandi L, Oriana S.
    Stem Cells; 1993 Nov; 11(6):528-35. PubMed ID: 7906583
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR, Abel G.
    Cancer Chemother Pharmacol; 1992 Nov; 30(6):444-50. PubMed ID: 1356649
    [Abstract] [Full Text] [Related]

  • 3. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
    Braakhuis BJ, Hill BT, Dietel M, Kelland LR, Aapro MS, Zoli W, Lelieveld P.
    Anticancer Res; 1994 Nov; 14(1A):205-8. PubMed ID: 7909419
    [Abstract] [Full Text] [Related]

  • 4. Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions.
    Munkarah A, Chuang L, Lotzová E, Cook K, Morris M, Wharton JT.
    Gynecol Oncol; 1994 Nov; 55(2):211-6. PubMed ID: 7959286
    [Abstract] [Full Text] [Related]

  • 5. Electrochemical monitoring of anticancer compounds on the human ovarian carcinoma cell line A2780 and its adriamycin- and Cisplatin-resistant variants.
    Woolley DE, Tetlow LC, Adlam DJ, Gearey D, Eden RD, Ward TH, Allen TD.
    Exp Cell Res; 2002 Feb 01; 273(1):65-72. PubMed ID: 11795947
    [Abstract] [Full Text] [Related]

  • 6. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
    Frankel A, Buckman R, Kerbel RS.
    Cancer Res; 1997 Jun 15; 57(12):2388-93. PubMed ID: 9192815
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers.
    Zoli W, Flamigni A, Frassineti GL, Bajorko P, De Paola F, Milandri C, Amadori D, Gasperi-Campani A.
    Breast Cancer Res Treat; 1995 Apr 15; 34(1):63-9. PubMed ID: 7749161
    [Abstract] [Full Text] [Related]

  • 8. Taxane sensitivity of ovarian carcinoma in vitro.
    Engblom P, Rantanen V, Kulmala J, Heiskanen J, Grenman S.
    Anticancer Res; 1997 Apr 15; 17(4A):2475-9. PubMed ID: 9252666
    [Abstract] [Full Text] [Related]

  • 9. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
    Rangel C, Niell H, Miller A, Cox C.
    Cancer Chemother Pharmacol; 1994 Apr 15; 33(6):460-4. PubMed ID: 7907952
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Apr 15; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 11. In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
    Jensen PB, Holm B, Sorensen M, Christensen IJ, Sehested M.
    Br J Cancer; 1997 Apr 15; 75(6):869-77. PubMed ID: 9062409
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol.
    Yu D, Liu B, Jing T, Sun D, Price JE, Singletary SE, Ibrahim N, Hortobagyi GN, Hung MC.
    Oncogene; 1998 Apr 23; 16(16):2087-94. PubMed ID: 9572489
    [Abstract] [Full Text] [Related]

  • 13. Taxotere inhibits in-vitro growth of human colonic cancer cell lines.
    Karantanis E, Nicholson S, Morris DL.
    Eur J Surg Oncol; 1994 Dec 23; 20(6):653-7. PubMed ID: 7995417
    [Abstract] [Full Text] [Related]

  • 14. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.
    Hanauske AR, Degen D, Hilsenbeck SG, Bissery MC, Von Hoff DD.
    Anticancer Drugs; 1992 Apr 23; 3(2):121-4. PubMed ID: 1356030
    [Abstract] [Full Text] [Related]

  • 15. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
    Yamamoto K, Kikuchi Y, Kudoh K, Hirata J, Kita T, Nagata I.
    Jpn J Clin Oncol; 2000 Oct 23; 30(10):446-9. PubMed ID: 11185891
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer.
    Boven E, Venema-Gaberscek E, Erkelens CA, Bissery MC, Pinedo HM.
    Ann Oncol; 1993 Apr 23; 4(4):321-4. PubMed ID: 8100146
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
    Sonnemann J, Gänge J, Pilz S, Stötzer C, Ohlinger R, Belau A, Lorenz G, Beck JF.
    BMC Cancer; 2006 Jul 11; 6():183. PubMed ID: 16834771
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
    Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL.
    Mol Cancer Ther; 2002 Nov 11; 1(13):1191-200. PubMed ID: 12479700
    [Abstract] [Full Text] [Related]

  • 19. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
    Hennequin C, Giocanti N, Favaudon V.
    Cancer Res; 1996 Apr 15; 56(8):1842-50. PubMed ID: 8620502
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel and docetaxel in breast and ovarian cancer.
    Drug Ther Bull; 1997 Jun 15; 35(6):43-6. PubMed ID: 9282422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.